Connection

Daniel Brinton to Costs and Cost Analysis

Back to Details
This is a "connection" page, showing publications Daniel Brinton has written about Costs and Cost Analysis.
Daniel Brinton
Connection Strength
0.046
Costs and Cost Analysis
  1. A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.